JPS59112909A - Cosmetic containing fat soluble elastin peptide - Google Patents
Cosmetic containing fat soluble elastin peptideInfo
- Publication number
- JPS59112909A JPS59112909A JP22555682A JP22555682A JPS59112909A JP S59112909 A JPS59112909 A JP S59112909A JP 22555682 A JP22555682 A JP 22555682A JP 22555682 A JP22555682 A JP 22555682A JP S59112909 A JPS59112909 A JP S59112909A
- Authority
- JP
- Japan
- Prior art keywords
- elastin peptide
- cosmetic
- containing fat
- formula
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000016942 Elastin Human genes 0.000 title claims abstract description 36
- 108010014258 Elastin Proteins 0.000 title claims abstract description 36
- 229920002549 elastin Polymers 0.000 title claims abstract description 36
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 35
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 5
- 150000007933 aliphatic carboxylic acids Chemical group 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 11
- 239000003921 oil Substances 0.000 abstract description 8
- 239000002253 acid Substances 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 239000003925 fat Substances 0.000 abstract description 4
- 210000003041 ligament Anatomy 0.000 abstract description 4
- 239000002585 base Substances 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000003974 emollient agent Substances 0.000 abstract description 2
- 238000011049 filling Methods 0.000 abstract description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 abstract 1
- 125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 1
- 238000005461 lubrication Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000008117 stearic acid Substances 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- -1 liquid paraffin Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000005639 Lauric acid Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical group OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- CKPOABDCSSXDCY-UHFFFAOYSA-N 2-propan-2-yltetradecanoic acid Chemical compound CCCCCCCCCCCCC(C(C)C)C(O)=O CKPOABDCSSXDCY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000087799 Koma Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- NGXUUAFYUCOICP-UHFFFAOYSA-N aminometradine Chemical group CCN1C(=O)C=C(N)N(CC=C)C1=O NGXUUAFYUCOICP-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
この発明は、@乳類動物皮膚組織を構成する蛋白線維質
又は血管壁から酸又はアルカリ、あるいは酵素分解処理
して得られる、油脂類に不溶ナエラスチンプロテイン分
解物をもとに得られた、一般式〔1〕中のnが2〜30
0のエラスチンペプチドに、脂肪族カルボン酸エステル
二
本発明による脂溶性エラスチンペプチドは、化粧料に用
いられるオイルヘースなどノm 脂類に対して、溶解性
が良好である。DETAILED DESCRIPTION OF THE INVENTION This invention provides a decomposition product of naelastin protein, which is insoluble in fats and oils, obtained by acid or alkali or enzymatic decomposition treatment from protein fibers or blood vessel walls constituting mammalian skin tissue. n in the originally obtained general formula [1] is 2 to 30
The fat-soluble elastin peptide of the present invention has good solubility in fats such as oil haze used in cosmetics.
従来から、エラスチン線維をもとに、これを化粧料に応
用する研究は、数多くなされてきたが、その応用に当っ
ては、あらがしめ動物皮膚組織の靭帯及び血管壁を用い
、これを酸又はアルカリ及びプロテナーゼ等の酵素分解
を加えて処理して、水に可溶なエラスチンペプチドを用
いるなどの利用が知られており、たとえば、〔公開特許
公報:昭53−101592)、〔Partidg、S
、M、、Davis H,F。Numerous studies have been conducted to apply elastin fibers to cosmetics. Alternatively, it is known to use elastin peptides that are soluble in water by treatment with alkali and enzymatic decomposition such as proteinase.
,M., ,Davis H,F.
及びAdair G、S、、(Biochem。and Adair G, S, (Biochem.
J、−一ユユ11〜21) 1955,1、(Kell
er S、、及びMandl、J、、(Eioche
m、Mediains −5,842〜84’7)1
971)、〔公開特許公報:昭53−72832) 、
(公開特許公報:昭54−105238)などがある。J, -1 Yuyu 11-21) 1955, 1, (Kell
er S., and Mandl, J., (Eioche
m, Mediains -5,842~84'7)1
971), [Publication Patent Publication: 1972-72832),
(Public Patent Publication: 1984-105238).
ニし
靭帯及び血管壁がら得られたところの水溶性タイプのエ
ラスチンペプチドの利用面の一つには、化粧料への利用
がある。しかし、従来のエラスチンペプチドは、いずれ
も化粧品類への配合に当って、水溶性であるがために、
油性タイプの化粧料ベースである、例えば、オリーブ油
、ヒマシ油、ヤシ油、その他の各種の植物油、流動パラ
フィン、ワセリン、セレシンなどの鉱物油、ミリスチン
酸イソプロピル、パルミチン酸イソプロピル、ミリスチ
ン酸オクチルドデシル等々の脂肪酸エステル類には、は
とんど溶けない欠点があった。つまり、従来はメチル、
エチル、又は、プロピルアルコール等の低級アルコール
類にはわずかに溶けるのみであった。そこで、ポリエチ
レングリコール、プロピレングリコール、ブチレングリ
コール等のポリオール類には可溶であることから、あら
かじめ、油性タイプの化粧料中に用いる際は、上述のポ
リオール類などを用いる必要があり、製剤化上、制約さ
れていた。つまり、油性タイプの化粧品類への配合は、
さらに、界面活性剤などを用いて。One of the uses of water-soluble elastin peptides obtained from the Nishin ligament and blood vessel walls is in cosmetics. However, since all conventional elastin peptides are water-soluble when incorporated into cosmetics,
Oil-based cosmetic bases, such as olive oil, castor oil, coconut oil, various other vegetable oils, liquid paraffin, petrolatum, mineral oils such as ceresin, isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, etc. Fatty acid esters have the disadvantage that they are rarely soluble. In other words, traditionally methyl,
It was only slightly soluble in lower alcohols such as ethyl or propyl alcohol. Therefore, since polyols such as polyethylene glycol, propylene glycol, and butylene glycol are soluble, it is necessary to use the above-mentioned polyols in advance when using them in oil-based cosmetics. , was restricted. In other words, when used in oil-based cosmetics,
Furthermore, using surfactants etc.
スチンベブチド本来のエモリエント効果又は特有の保湿
滑性フィリング効果が、低下するなどの欠点があった。There were drawbacks such as a decrease in the emollient effect or unique moisturizing and slippery filling effect inherent to stinbebutide.
そこで本発明者らは、化粧料に繁用される、オイルベー
ス中で可溶なエラスチンペプチド化について研究を続け
た結果、以下に述べるごと<脂溶性エラスチンペプチド
を得ることに成功するに至った。Therefore, the present inventors continued their research on elastin peptides that are soluble in oil bases, which are often used in cosmetics, and as a result, they succeeded in obtaining fat-soluble elastin peptides as described below. .
本発明による脂溶性エラスチンペプチド(以下、便宜上
OEPと略記する)の製造法を示せば、たとえば、靭帯
又は血管壁をもとに、従来の公知な暇やアルカリ又は酵
素を用いて分解処理されて得られたエラスチンペプチド
に、脂肪族カルボン酸エステルなどを用いることが出来
、これを式示すれば、次のごとくである。A method for producing fat-soluble elastin peptide (hereinafter abbreviated as OEP for convenience) according to the present invention is, for example, by decomposing the peptide from ligament or blood vessel walls using conventional methods, alkali, or enzymes. For the obtained elastin peptide, an aliphatic carboxylic acid ester or the like can be used, and the formula thereof is as follows.
式中Rは脂肪族又は芳香族カルボン酸残基であり、R′
はアルキル基、さらにXは塩素又は臭素を示す。In the formula, R is an aliphatic or aromatic carboxylic acid residue, and R'
represents an alkyl group, and X represents chlorine or bromine.
H2N ((! He ON +()nOHCOOH
+ ROOX + N ao HR′
上述した。gpの製造における、アシル化法としては、
他の物質における5chotten−E a u m
a m n反応に準拠して行えば良い〇〔製造法〕
血管壁か又は靭帯を用い、この組織中に含まれるエラス
チンペプチドを、アルカリ処理、酸処理を行った後、沸
騰(熱)シュウ酸処理法、アルコールを含むアルカリ氷
解法又はエラスターゼ消化法などにより抽出して得られ
た、エラスチンペプチドの溶液を、4基400−を取り
希アルカリ溶液を加えて、pHが9.5〜12.0とな
し、40〜90℃の温度でカルボン酸ハロゲナイドを約
609を30分間〜18時間程度を要して、攪拌下で滴
下し、滴下終了後、同温度で更に数時間攪拌する。次い
で希硫酸溶液にて、p H4,0以下となし、濾過して
未反応物のエラスチンペプチド及び溶媒を除去した後の
粗製物を、水中で分散させ、暖やかに攪拌してから加え
抽出を行ったのち、再結晶化を行って、精製OKPが得
られる。H2N ((! He ON +()nOHCOOH
+ ROOX + N ao HR' As mentioned above. The acylation method in the production of gp is as follows:
5chotten-E aum in other substances
It can be carried out according to the a m n reaction 〇 [Production method] Using the blood vessel wall or ligament, the elastin peptide contained in this tissue is treated with alkali and acid, and then boiled (heated) oxalic acid. A solution of elastin peptide extracted by a treatment method such as an alkaline ice-melting method containing alcohol or an elastase digestion method is prepared by adding a dilute alkaline solution to a solution of elastin peptide having a pH of 9.5 to 12.0. Then, about 60% of carboxylic acid halide is added dropwise at a temperature of 40 to 90°C with stirring over a period of about 30 minutes to 18 hours, and after the dropwise addition is completed, the mixture is further stirred at the same temperature for several hours. Next, the pH was adjusted to 4.0 or less with a dilute sulfuric acid solution, and the crude product after filtering to remove unreacted elastin peptide and solvent was dispersed in water, stirred warmly, and added for extraction. After this, purified OKP is obtained by recrystallization.
これによって得られた、新規アシル化エラスチンペプチ
ド化合物は、淡黄色〜淡黄褐色の結晶体で、水には難溶
又は不溶であるが、各種の有機溶媒をはじめ、従来のエ
ラスチンペプチドでは不溶であった、各種の植物油、鉱
物油、各種の脂肪酸エステル類に良く溶け、しかもステ
アリン酸、バルミチン酸などの高級脂肪酸エステル体に
も溶解できるようになった。The novel acylated elastin peptide compound thus obtained is a pale yellow to pale yellowish brown crystalline substance that is sparingly soluble or insoluble in water, but is insoluble in various organic solvents and conventional elastin peptides. It is highly soluble in various vegetable oils, mineral oils, and various fatty acid esters, and can also be dissolved in higher fatty acid esters such as stearic acid and valmitic acid.
前記した製造法に準拠して得られたogpにおいて、例
えばエラスチンペプチドーステアリン酸アシル化合物と
なしたものと、公知なエラスチンペプチドについて、比
較検討を加えてみると、ビユレット反応では、両者共に
赤紫〜青紫を呈する。紫外部吸収スペクトル(アルコー
ル溶液)についてみると、第1図に示すごとくとなり、
両者間では、とくに顕著な紫外部吸収は認められないが
、ただ250〜280nmの広範囲にわたる、ブロード
なショルダーを示す点が、従来のエラスチンペプチドと
異なっている。Comparing the ogp obtained according to the above-mentioned production method, for example, an elastin peptide-acyl stearate compound and a known elastin peptide, it was found that in the Biillet reaction, both of them produced a reddish-purple color. ~Exhibits a bluish-purple color. Looking at the ultraviolet absorption spectrum (alcohol solution), it is as shown in Figure 1,
Although no particularly significant ultraviolet absorption is observed between the two, they differ from conventional elastin peptides in that they exhibit a broad shoulder over a wide range of 250 to 280 nm.
一方、安定性については、低分子化されたエラスチンペ
プチドに比べ、アシル化合物では、いずれも対日光照射
や加熱条件下において、褐変化現象が抑制されることで
ある。つまり従来の低分子なエラスチンペプチドでは、
日光や加熱条件下で長時間さらすと、褐変化が進むため
に、化粧料等に配合した製品化後の安定性については、
十分な配慮が必要であったが、この要因としてはエラス
チンペプチドの主な構成アミノ酸である、グリシン、ア
ラニンが、糖類及び紫外線や熱などの影響を受けて、窒
素配糖体となり、次いでアマトリ転位を起して、アミ7
−カルボニール反応が終了したとき、褐変化が進行する
と考えられている。On the other hand, regarding stability, the browning phenomenon is suppressed in all acyl compounds under sunlight irradiation and heating conditions, compared to elastin peptides made into low-molecular-weight molecules. In other words, with conventional low-molecular elastin peptides,
If exposed to sunlight or heat for a long time, browning will progress, so the stability of products after they are incorporated into cosmetics, etc.
Although sufficient consideration was required, this is because glycine and alanine, the main constituent amino acids of elastin peptide, become nitrogen glycosides under the influence of sugars, ultraviolet rays, and heat, and then undergo Amatoli rearrangement. Wake up, Ami7
- It is believed that browning progresses when the carbonyl reaction is completed.
本発明によるOEPでは、このような着色傾向が、著し
く改善されることがわかった。しかも、このOEFのメ
リットは、その化合構造からも理解されるごとく、界面
活性剤としての条件を備えているために、乳化、分散性
が著しく良好である。したがって、クリーム、乳液等々
における使用は容易となった。本発明によるOEFの溶
解性は、第1表中に示すごとくである0尚、第1表中で
は、OEFとして、前記の製造法に準拠してステアリン
酸及びラウリン酸を用いて得られた化合物について示し
たが、製造に当っては、他の脂肪族カルボン酸エステル
、芳香族カルボン酸エステルから、任意に選択して製造
すれば、いずれもOEF化が可能であるしかも本発明に
おけるOEPの製法は、そのすべてにおいて、従来から
知られている5chotten、−Baumamn反応
を採用すれば出来ることで、特別に条件を限定する必要
もない0
また、出発原料であるエラスチンペプチドについては、
とくに精製されたものを用いなくてもよいが、分子量が
大きいときでは、ポリペプチドのN末端にしか脂肪酸が
結合しないこととなり、このために、製造されたOKP
は有機溶媒及び水に対しても不溶となるから、エラスチ
ンペプチドの分子量の上限を、約3万のポリペプチドか
ら、下限では約200のジペプチドに求めること、の方
が良い。It has been found that in the OEP according to the present invention, such coloring tendency is significantly improved. Moreover, as can be understood from its chemical structure, the advantage of OEF is that it has excellent emulsifying and dispersing properties because it has the requirements as a surfactant. Therefore, it has become easy to use in creams, emulsions, etc. The solubility of OEF according to the present invention is as shown in Table 1. In Table 1, OEF is a compound obtained using stearic acid and lauric acid according to the above-mentioned production method. However, in production, if any other aliphatic carboxylic acid ester or aromatic carboxylic acid ester is selected and produced, any of them can be converted into OEF. All of these can be done by using the conventionally known 5chotten, -Baumamn reaction, and there is no need to limit the conditions.
It is not necessary to use particularly purified OKP, but when the molecular weight is large, the fatty acid will bind only to the N-terminus of the polypeptide, and for this reason, the produced OKP
Since it is also insoluble in organic solvents and water, it is better to set the upper limit of the molecular weight of the elastin peptide to a polypeptide of about 30,000 to a dipeptide of about 200 as the lower limit.
一方、毛髪用としては、ヘアーカラーの如く、毛髪自体
に吸収させることを目的とすれば、得られたOEPの分
子量が、約400〜600程度にすると最適である。し
たがって、化粧料配合用としては、OEPの製造の際に
用いるエラスチンペプチドは、トリペプチド又はテトラ
ペプチドが有利である。さらに、化粧料において、これ
を肌に塗布して、表皮における被膜性を発゛揮させるよ
うなときでは、OEPの分子量は1万〜3万が最適であ
る。On the other hand, for hair applications such as hair coloring, if the purpose is to absorb it into the hair itself, it is optimal if the obtained OEP has a molecular weight of about 400 to 600. Therefore, for use in cosmetic formulations, tripeptides or tetrapeptides are advantageously used as the elastin peptides used in the production of OEP. Furthermore, when applying cosmetics to the skin to exhibit film properties on the epidermis, the optimal molecular weight of OEP is 10,000 to 30,000.
〔第1表〕 (溶解性)
さらに、前記のOEPの製造法では、脂肪族カルボン酸
エステルとしてステアリン酸、ラウリン酸を用いて実施
したが、これを低級脂肪酸や、芳香族カルボン酸エステ
ルを用いたときでは、油脂類への溶解性は低下するも、
エタノールなどには非常に良く溶けるために、化粧水な
どや、ヘアートニックなどの処方中に、エタノールを高
含有する様な場合では有利である。[Table 1] (Solubility) Furthermore, in the above-mentioned OEP manufacturing method, stearic acid and lauric acid were used as aliphatic carboxylic acid esters, but this was carried out using lower fatty acids and aromatic carboxylic acid esters. Although the solubility in oils and fats decreases when
Because it is highly soluble in ethanol, it is advantageous in formulations such as lotions and hair tonics that contain high amounts of ethanol.
本発明によるOKPについて、製造法で示したステアリ
ン酸及びラウリン酸を用いて、得られた化合物の、安全
性についてFDA (アメリカ連邦食品医薬品化粧品法
にもとすく安全性試験法)に準拠して、皮膚−次刺激、
眼粘膜−次刺激、光毒性、接触性アレルギー等について
実施したが、いずれの試験においても、何ら毒性作用は
認められず、安全性は高いものであることが確認され、
皮膚外用塗布されても安全性には不安がないものである
。尚、マウス(♂)による経口投与による、LD50値
は、5ooO■/ kq以上であった。Regarding OKP according to the present invention, the safety of the compound obtained using stearic acid and lauric acid shown in the manufacturing method was determined in accordance with the FDA (Federal Food, Drug, and Cosmetic Act). , skin-secondary irritation,
Tests were conducted on ocular mucosal irritation, phototoxicity, contact allergies, etc., and no toxic effects were observed in any of the tests, confirming that the product is highly safe.
There is no concern about safety when applied externally to the skin. The LD50 value obtained by oral administration to mice (male) was 5ooO■/kq or more.
次に、本発明によるO E Pについての化粧料への添
加について、2〜3の処方例を示す。Next, two to three formulation examples will be shown regarding the addition of OEP according to the present invention to cosmetics.
(1) OK F含有乳液
エラスチンペプチド−ステアリン酸化合物(OEP)−
@・・・・−・・・・彎・・・・・・・l O,0%カ
ルボキシポリマー・・・・・・・・・・・ 0.2グ
リ セ リ ン ・・・・拳・−・・・・・・・嘩e書
・・ 2 1.0エタノール・ll11@Φ・・・・・
・・・1・−−−−7,0セタノール拳・・・S・・・
・・Φ・・・・・・・・ 0021.3−ブチレングリ
コール・・・ 260イソプロピルミリスチン酸e@・
・・ 0.5香料及び防腐剤・・・・・・・・・・・・
・・・ 適量精製水をもって、全量・・・・・・100
%とする。(1) OK F-containing emulsion elastin peptide - stearic acid compound (OEP) -
@・・・・−・・・・・・・・・・・l O, 0% carboxy polymer・・・・・・・・・ 0.2g
Ri Serin...Fist...Fighting e-book...2 1.0 Ethanol・ll11@Φ...
...1・----7,0 Setanol Fist...S...
・・Φ・・・・・・ 0021.3-Butylene glycol... 260 isopropyl myristic acid e@・
・・・ 0.5 Fragrance and preservatives・・・・・・・・・・・・
... Add an appropriate amount of purified water, total amount...100
%.
(OE P) ・・1・φ・・■−・・・・−−−−
7,0%モノオレイン酸オクチルドデシル・ 8.0モ
ノオレイン酸グリセリンss−令・ 9.0ラノリン・
・・昏・・・・11管・・−・・・・・・・113.0
セタノール@@場も@Il◆II舎ll5s◆弗S巻$
書12.0ステアリン酸・・・・・・・・参・・・曇・
・・・ 1.5流動パラフイン・・・・・Φ・−・・Φ
・・・ 8.0セレシン・・・・・−・・・・e・l・
1・・・・ 2.0香料及び防腐剤・・・・・・・・・
・・・・・・ 適量精製水をもって全量・・・・・10
0%とする。(OE P) ・・1・φ・・■−・・・・−−−−
7.0% octyldodecyl monooleate, 8.0 glycerin monooleate, 9.0 lanolin,
・・Koma・・11 tube・・・・・・・・・・113.0
Setanol @ @ Ba Mo @ Il ◆ II building ll5s ◆ Volume S $
Book 12.0 Stearic acid...Reference...Cloudy...
... 1.5 Liquid paraffin...Φ・-・・Φ
... 8.0 Ceresin...--e・l・
1...2.0 Fragrances and preservatives...
...... Total amount with appropriate amount of purified water...10
Set to 0%.
(a) OE P含有ヘアーリンス
エラスチンペプチド−プロピオン酸化合物(OE P)
・・・・・・・・1■・・e・・・・12.Q %
ポリビニールピロリドン・・・・・・・ 1.8水溶性
ラノリン・・・・・・・・・・・・・・・ 1.5エ
デ ト 酸 2 ブー ト リ ウ ム ・拳中中・・
・・−0,25エタノール・・−−0・・IIII・・
@骨−・0・e・ 5.0香料及び防腐剤・・・・・
・・・・・・・・・・ 適母精製氷をもって全量・・・
・・100%とする。(a) OE P-containing hair rinse elastin peptide-propionic acid compound (OE P)
......1■...e...12. Q%
Polyvinyl pyrrolidone・・・・・・ 1.8 Water-soluble lanolin・・・・・・・・・・・・ 1.5
Detox acid 2 boot lium ・In the middle of the fist...
・・−0,25 ethanol・・−0・・III・・
@bone-・0・e・5.0 Fragrance and preservative...
・・・・・・・・・・The whole amount with appropriate purified ice...
...Set as 100%.
一方、本発明によるOEPについて、チロシナーゼ活性
抑制作用についてみると、従来の水溶性のエラスチンペ
プチドと同様に、チロシナーゼ活性を抑制し、メラニン
の生成抑制能を有することかわかった。このことは肌の
美白的効果が期待されることから化粧料には有利である
。第2表は、それぞれの検体を用いた検液(A液)を調
整し、その2Qiをシャーレ中に注加して、冷却凝固さ
せて、その上に0.5%チロシナーゼ液を流し、37℃
の恒温槽中に所定時間放置し、寒天表面の黒化される程
度を観察し、チ・ナーゼ活性抑制作用=、メラ=ン色素
の生成(黒化)の有無についてみたものである〔第2表
〕 (チロシナーゼ活性抑制作用)On the other hand, when looking at the tyrosinase activity suppressing effect of OEP according to the present invention, it was found that it suppresses tyrosinase activity and has the ability to suppress melanin production, similar to conventional water-soluble elastin peptides. This is advantageous for cosmetics since it is expected to have a skin whitening effect. Table 2 shows that a test solution (liquid A) was prepared using each sample, 2Qi was poured into a petri dish, cooled and solidified, and a 0.5% tyrosinase solution was poured over it. ℃
The agar was left in a constant temperature bath for a predetermined period of time, and the degree of blackening of the agar surface was observed, and the presence or absence of the inhibitory effect on chinase activity and the production of melanin pigment (blackening) was examined. Table] (Tyrosinase activity inhibition effect)
第1図は、エラスチンペプチド−ステアリン酸化合物(
OE P)と、エラスチンペプチド、ステアリン酸の紫
外部吸収スペクトルを示したものである。
Aは、エラスチンペプチド(平均分子量1500)−ス
テアリン酸アシル化合物
Bは、エラスチンペプチド(平均分子量1500)
Cは、ステアリン酸
特許出願人
第1図Figure 1 shows the elastin peptide-stearic acid compound (
This figure shows the ultraviolet absorption spectra of OE P), elastin peptide, and stearic acid. A is elastin peptide (average molecular weight 1500) - acyl stearate compound B is elastin peptide (average molecular weight 1500) C is stearic acid Patent Applicant Figure 1
Claims (1)
ルキル基を示す。)で示される、脂溶性エラスチンペプ
チド含有化粧料。[Scope of Claims] A cosmetic composition containing a fat-soluble elastin peptide represented by the general formula (1) of elastin peptide (wherein R represents an aliphatic carboxylic acid residue and R' represents an alkyl group).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22555682A JPS59112909A (en) | 1982-12-21 | 1982-12-21 | Cosmetic containing fat soluble elastin peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22555682A JPS59112909A (en) | 1982-12-21 | 1982-12-21 | Cosmetic containing fat soluble elastin peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS59112909A true JPS59112909A (en) | 1984-06-29 |
Family
ID=16831140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22555682A Pending JPS59112909A (en) | 1982-12-21 | 1982-12-21 | Cosmetic containing fat soluble elastin peptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59112909A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125837B1 (en) | 1999-02-26 | 2006-10-24 | University Of Utah Research Foundation | Elastin-based compositions |
CN114573682A (en) * | 2022-03-08 | 2022-06-03 | 华南理工大学 | Elastin peptide and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5372832A (en) * | 1976-12-11 | 1978-06-28 | Bayer Ag | Cosmetic agent |
JPS53101592A (en) * | 1977-02-11 | 1978-09-05 | Roehm Gmbh | Production of water soluble erastine hydrolysate |
JPS54105238A (en) * | 1978-01-31 | 1979-08-18 | Freudenberg Carl | Protein base acting substance for skin makeeup |
-
1982
- 1982-12-21 JP JP22555682A patent/JPS59112909A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5372832A (en) * | 1976-12-11 | 1978-06-28 | Bayer Ag | Cosmetic agent |
JPS53101592A (en) * | 1977-02-11 | 1978-09-05 | Roehm Gmbh | Production of water soluble erastine hydrolysate |
JPS54105238A (en) * | 1978-01-31 | 1979-08-18 | Freudenberg Carl | Protein base acting substance for skin makeeup |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125837B1 (en) | 1999-02-26 | 2006-10-24 | University Of Utah Research Foundation | Elastin-based compositions |
CN114573682A (en) * | 2022-03-08 | 2022-06-03 | 华南理工大学 | Elastin peptide and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3532244B2 (en) | Mucopolysaccharide fragmentation inhibitor, active oxygen scavenger and cosmetic | |
JPS6078914A (en) | Cosmetics and pharmaceutical compositions | |
EP0824915B1 (en) | Use of glycoglycerolipids as surfactants and cosmetic or dermatological compositions containing them | |
JPH11263720A (en) | Antiaging agent | |
JP2003300859A (en) | Skin care preparation | |
JP3544609B2 (en) | Anti-aging agent | |
JPS60112708A (en) | Humectant for skin | |
KR20010102559A (en) | Composition for cosmetic and dermatological skin care | |
JP3290291B2 (en) | Active oxygen scavenger and composition containing the same | |
JPH1029927A (en) | Antiaging agent | |
JPS59112909A (en) | Cosmetic containing fat soluble elastin peptide | |
JPH11246337A (en) | Antiaging agent | |
JPH11246387A (en) | Antiaging agent | |
JP6666737B2 (en) | Composition useful as external preparation for skin or cosmetic | |
JP2000096050A (en) | Promoter for production of hyaluronic acid | |
JP3140876B2 (en) | Melanin production inhibitor and external preparation for skin | |
JP3885243B2 (en) | Skin cosmetics | |
JPH07149622A (en) | Beautifying and whitening preparation | |
JPH0632710A (en) | Skin external preparation | |
JP2003206279A (en) | Pyridoxine derivative and skin care preparation and hair cosmetic containing the same pyridoxine derivative | |
JPH0696511B2 (en) | Cosmetics | |
JP4653513B2 (en) | Skin preparation | |
JPS59112951A (en) | Fat-soluble elastin peptide | |
JP4309190B2 (en) | Topical skin preparation | |
KR101894433B1 (en) | Composition for skin whitening comprising tofu sunmul |